Butyrylcholinesterase (BChE) is an enzyme that is altered in could neuroblastoma patients.302 When comparing BChE activity in MYCN amplified patients, this is around 40% lower than compared to non-MCYN amplified cases. This evidence concerns the gene BCHE and neuroblastoma.